Concert Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNCE and other ETFs, options, and stocks.

About CNCE

Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. 

CEO
Roger D. Tung
CEORoger D. Tung
Employees
64
Employees64
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2006
Founded2006
Employees
64
Employees64

CNCE Key Statistics

Market cap
322.60M
Market cap322.60M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
418.27K
Average volume418.27K
High today
$6.88
High today$6.88
Low today
$6.19
Low today$6.19
Open price
$6.19
Open price$6.19
Volume
970.14K
Volume970.14K
52 Week high
$7.37
52 Week high$7.37
52 Week low
$2.57
52 Week low$2.57

CNCE Earnings

-$1.03
-$0.63
-$0.24
$0.16
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 9, Pre-Market
ActualExpected Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.